Compare Enveric Biosciences Inc (ENVB) vs Hormel Foods Corp (HRL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Hormel Foods Corp — how do they compare? Enveric Biosciences Inc trades at $1.38 (market cap $5.32M), while Hormel Foods Corp trades at $25.81 (market cap $13.84B). The key difference: Hormel Foods Corp is far larger — about 2601.5× Enveric Biosciences Inc's market cap, and Hormel Foods Corp pays a 4.65% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | HRL | |
|---|---|---|
Market Cap | $5.32M | $13.84B |
Sector | Health | Consumer Staples |
52-Week High | $17.40 | $29.91 |
52-Week Low | $1.28 | $19.74 |
Enterprise Value | $408.82K | $15.84B |
Dividend Yield | — | 4.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
Hormel Foods (HRL) trades at $25.76, up 3.87% today, with a bullish technical signal from moving averages. The company has beaten EPS estimates for three consecutive quarters, though net income margin declined to 3.82% in 2025. Recent news highlights its status as a Dividend King with 60 years of consecutive increases and strategic moves like selling its Brazilian Ceratti business to sharpen growth focus.
Outlook remains cautious with mixed analyst sentiment (20% buy, 57% hold) and a consensus target of $26.33. Opportunities include dividend reliability and operational streamlining, but risks involve margin pressure and competitive food industry dynamics. The stock offers value near multi-year lows but requires patience amid earnings volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →
